Catalyst
Slingshot members are tracking this event:
Esperion plans to announce top-line results from the Phase 1 (1002-037) and Phase 2 (1002-035) clinical studies of bempedoic acid and high-dose statins
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ESPR | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 13, 2016
Occurred Source:
https://globenewswire.com/news-release/2016/10/13/879205/0/en/Bempedoic-Acid-Global-Phase-3-Clinical-Program-to-Include-Patients-on-Any-Statin-at-Any-Dose.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bempedoic Acid, High-dose Statins
